Purity programme · not started
What is actually in the vial?
For a gray-market compound, the live question is often not what it does in a rat but what was sold. No published results exist here yet, and none will appear until the protocol below has had legal review.
Planned design
| Element | Plan |
|---|---|
| Procurement | Blinded retail purchase, documented chain of custody from purchase to laboratory. |
| Assay panel | Identity (LC-MS/MS), purity (HPLC), quantity against label claim, endotoxin (LAL), sterility; for lyophilised injectables, visible particulates and residual solvents. |
| Laboratory | Independent analytical laboratory with no commercial relationship to any vendor. |
| Publication | Full methods and full results, vendor-named, passes and failures alike, in a form a critic could replicate. |
Status
Not started. Purchasing unapproved drugs, even for analysis, raises legal questions that differ by jurisdiction, so counsel reviews the protocol before any procurement. This page will say when that has happened.
Purity results do not imply that a product is safe or effective to use. A pure compound with no human evidence is still a compound with no human evidence.